Latest available resultsQuarter ended June 30, 202610-Q · August 10, 2026
Filed with the SECHims & Hers Health, Inc.
HIMSHealthcare
Next reportNovember 2, 2026Analyst forecast 0.081 $/share
Revenue
$753.21M
▲ +38.2% vs prior year% YoY
Net income
−$86.29M
▼ -303.0% vs prior year% YoY
EPS
-0.37$
▼ -317.6% vs prior year% YoY
Net margin
-11.5%
▼ -19.3 percentage points vs prior year pp YoY
Revenue▲ +38.2 %
Margins (% of revenue)GrossOperatingNet
Net income▼ -303.0 %
EPS▼ -317.6 %
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $753.21M | |
| Gross profit | $480.80M | 63.8 % |
| Operating income | −$97.19M | -12.9 % |
| Net income | −$86.29M | -11.5 % |
| R&D | — | never filed |
| EPS (diluted) | -0.37 $ | |
| Balance sheet | ||
| Assets | $3.63B | |
| Liabilities | $3.30B | |
| Equity | $324.07M | |
| Cash | $609.81M | |
| Capital | ||
| Shares outstanding | — | never filed |
| Public float | — | |